UB Paderborn / Katalog / Suche / in CDI

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

PloS one, 2018-06, Vol.13 (6), p.e0199760-e0199760

2018

Link zum Volltext

Verfügbarkeit prüfen

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study

Alimentary pharmacology & therapeutics, 2018-11, Vol.48 (9), p.993-1002

2018

Link zum Volltext

Verfügbarkeit prüfen

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

PloS one, 2020-11, Vol.15 (11), p.e0242113-e0242113

2020

Link zum Volltext

Verfügbarkeit prüfen

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Alimentary pharmacology & therapeutics, 2020-12, Vol.52 (11-12), p.1695-1706

2020

Link zum Volltext

Verfügbarkeit prüfen

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

PloS one, 2019-10, Vol.14 (10), p.e0222605-e0222605

2019

Link zum Volltext

Verfügbarkeit prüfen

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Journal of gastroenterology and hepatology, 2017-12, Vol.32 (12), p.1975-1981

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

PloS one, 2024, Vol.19 (3), p.e0290523-e0290523

2024

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Cancers, 2022-01, Vol.14 (2), p.343

2022

Link zum Volltext

Verfügbarkeit prüfen

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

PloS one, 2019-10, Vol.14 (10), p.e0222196-e0222196

2019

Link zum Volltext

Verfügbarkeit prüfen

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Investigational new drugs, 2020-02, Vol.38 (1), p.202-210

2020

Link zum Volltext

Verfügbarkeit prüfen

Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation

Cancers, 2023-06, Vol.15 (12), p.3156

2023

Link zum Volltext

Verfügbarkeit prüfen

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

PloS one, 2019-01, Vol.14 (1), p.e0208858

2019

Link zum Volltext

Verfügbarkeit prüfen

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients

Cancers, 2023-02, Vol.15 (4), p.1222

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Frontiers in oncology, 2021-10, Vol.11, p.737767-737767

2021

Link zum Volltext

Verfügbarkeit prüfen

Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships

Viruses, 2022-02, Vol.14 (2), p.304

2022

Link zum Volltext

Verfügbarkeit prüfen

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology

Cancers, 2023-03, Vol.15 (6), p.1687

2023

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Frontiers in oncology, 2021-05, Vol.11, p.683341-683341

2021

Link zum Volltext

Verfügbarkeit prüfen

Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019

Viruses, 2022-12, Vol.15 (1), p.126

2022

Link zum Volltext

Verfügbarkeit prüfen

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

Investigational new drugs, 2018-04, Vol.36 (2), p.307-314

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis

Expert review of gastroenterology & hepatology, 2017-04, Vol.11 (4), p.277-279

2017

Link zum Volltext

Verfügbarkeit prüfen

Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia

Surgical oncology, 2022-06, Vol.42, p.101769-101769, Article 101769

2022

Link zum Volltext

Verfügbarkeit prüfen

Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships

Journal of the Formosan Medical Association, 2022-09, Vol.121 (9), p.1850-1856

2022

Link zum Volltext

Verfügbarkeit prüfen

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients

European journal of cancer (1990), 2008-05, Vol.44 (7), p.1000-1006

2008

Link zum Volltext

Verfügbarkeit prüfen

Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients

Journal of gastroenterology and hepatology, 2016-07, Vol.31 (7), p.1307-1314

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma

Journal of gastroenterology and hepatology, 2015-02, Vol.30 (2), p.358-363

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level

Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population‐based study

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation

Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan

Active hepatocellular carcinoma is an independent risk factor of direct-acting antiviral treatment failure: A retrospective study with prospectively collected data

Albumin‐Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Hepatitis B virus-related hepatocellular carcinoma has superior overall survival compared with other etiologies

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab

Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening

The influence of direct-acting antivirals in hepatitis C virus related hepatocellular carcinoma after curative treatment

Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation

Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis

Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships

Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology

Nivolumab Versus Regorafenib in Patients With Hepatocellular Carcinoma After Sorafenib Failure

Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019

The outcome of sorafenib monotherapy on hepatocellular carcinoma with portal vein tumor thrombosis

Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis

Minimally invasive surgery versus percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma: Results from a high-volume liver surgery center in East Asia

Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients

Three-year efficacy and safety of tenofovir in nucleos(t)ide analog-naïve and nucleos(t)ide analog-experienced chronic hepatitis B patients

Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma

Suchergebnisse filtern